ArticleCancer biology & medicine2023
Cohort profile: design and methods of the Chinese colorectal, breast, lung, liver, and stomach cancer screening trial (C-BLAST).
Open access · goldAbstract readEditorial
In one paragraph
Article in Cancer biology & medicine, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.
0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
2.3field-weighted citation impact, top 12% of its field
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
4 citing papers in PubMed, 8 citations in OpenAlex.
- Cohort profile: the National Early Gastrointestinal Cancer Cohort (NEGCC) study in China.Surgical endoscopy · 2026Article
- Global burden of female breast cancer: new estimates in 2022, temporal trend and future projections up to 2050 based on the latest release from GLOBOCAN.Journal of the National Cancer Center · 2025Article
- Integrated analysis of microbiota and gut microbial metabolites in blood for breast cancer.mSystems · 2024Article
- Effects of joint screening for prostate, lung, colorectal, and ovarian cancer - results from a controlled trial.Frontiers in oncology · 2024Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
24 authors at 1 institution in 1 country.
Yubei Huang *Department of Cancer Epidemiology and Biostatistics, Key Laboratory of Molecular Cancer Epidemiology (Tianjin), Tianjin Medical University Cancer Institute & Hospital, National Clinical Research Center for Cancer, Key Laboratory of Cancer Prevention and Therapy, Tianjin's Clinical Research Center for Cancer, Tianjin 300060, China.
Zhangyan Lyu *Department of Cancer Epidemiology and Biostatistics, Key Laboratory of Molecular Cancer Epidemiology (Tianjin), Tianjin's Clinical Research Center for Cancer, National Clinical Research Center for Cancer, Tianjin Medical University Cancer Institute and Hospital, Tianjin 300060, China.
Yu ZhangDepartment of Cancer Epidemiology and Biostatistics, Key Laboratory of Molecular Cancer Epidemiology (Tianjin), Tianjin's Clinical Research Center for Cancer, National Clinical Research Center for Cancer, Tianjin Medical University Cancer Institute and Hospital, Tianjin 300060, China.
Xiaomin LiuDepartment of Cancer Epidemiology and Biostatistics, Key Laboratory of Molecular Cancer Epidemiology (Tianjin), Tianjin's Clinical Research Center for Cancer, National Clinical Research Center for Cancer, Tianjin Medical University Cancer Institute and Hospital, Tianjin 300060, China.
Yacong ZhangDepartment of Cancer Epidemiology and Biostatistics, Key Laboratory of Molecular Cancer Epidemiology (Tianjin), Tianjin's Clinical Research Center for Cancer, National Clinical Research Center for Cancer, Tianjin Medical University Cancer Institute and Hospital, Tianjin 300060, China.
Ya LiuDepartment of Cancer Epidemiology and Biostatistics, Key Laboratory of Molecular Cancer Epidemiology (Tianjin), Tianjin's Clinical Research Center for Cancer, National Clinical Research Center for Cancer, Tianjin Medical University Cancer Institute and Hospital, Tianjin 300060, China.
Chao ShengDepartment of Cancer Epidemiology and Biostatistics, Key Laboratory of Molecular Cancer Epidemiology (Tianjin), Tianjin's Clinical Research Center for Cancer, National Clinical Research Center for Cancer, Tianjin Medical University Cancer Institute and Hospital, Tianjin 300060, China.
Hongyuan DuanDepartment of Cancer Epidemiology and Biostatistics, Key Laboratory of Molecular Cancer Epidemiology (Tianjin), Tianjin's Clinical Research Center for Cancer, National Clinical Research Center for Cancer, Tianjin Medical University Cancer Institute and Hospital, Tianjin 300060, China.
Zeyu FanDepartment of Cancer Epidemiology and Biostatistics, Key Laboratory of Molecular Cancer Epidemiology (Tianjin), Tianjin's Clinical Research Center for Cancer, National Clinical Research Center for Cancer, Tianjin Medical University Cancer Institute and Hospital, Tianjin 300060, China.
Chenyang LiDepartment of Cancer Epidemiology and Biostatistics, Key Laboratory of Molecular Cancer Epidemiology (Tianjin), Tianjin's Clinical Research Center for Cancer, National Clinical Research Center for Cancer, Tianjin Medical University Cancer Institute and Hospital, Tianjin 300060, China.
Xiao LinDepartment of Cancer Epidemiology and Biostatistics, Key Laboratory of Molecular Cancer Epidemiology (Tianjin), Tianjin's Clinical Research Center for Cancer, National Clinical Research Center for Cancer, Tianjin Medical University Cancer Institute and Hospital, Tianjin 300060, China.
Zhuowei FengDepartment of Cancer Epidemiology and Biostatistics, Key Laboratory of Molecular Cancer Epidemiology (Tianjin), Tianjin's Clinical Research Center for Cancer, National Clinical Research Center for Cancer, Tianjin Medical University Cancer Institute and Hospital, Tianjin 300060, China.
Lu ZhengDepartment of Cancer Epidemiology and Biostatistics, Key Laboratory of Molecular Cancer Epidemiology (Tianjin), Tianjin's Clinical Research Center for Cancer, National Clinical Research Center for Cancer, Tianjin Medical University Cancer Institute and Hospital, Tianjin 300060, China.
Zhaoxiang YeDepartment of Radiology, Tianjin Medical University Cancer Institute and Hospital, Tianjin 300060, China.
Hong LuDepartment of Breast Imaging Diagnosis, Tianjin Medical University Cancer Institute and Hospital, Tianjin 300060, China.
Ying ZhuDepartment of Breast Imaging Diagnosis, Tianjin Medical University Cancer Institute and Hospital, Tianjin 300060, China.
Dejun ZhouDepartment of Endoscopy, Tianjin Medical University Cancer Institute and Hospital, Tianjin 300060, China.
Xi WeiDepartment of Ultrasound Imaging Diagnosis, Tianjin Medical University Cancer Institute and Hospital, Tianjin 300060, China.
Li RenDepartment of Clinical Laboratory, Tianjin Medical University Cancer Institute and Hospital, Tianjin 300060, China.
Bin MengDepartment of Pathology, Tianjin Medical University Cancer Institute and Hospital, Tianjin 300060, China.
Fangfang SongDepartment of Cancer Epidemiology and Biostatistics, Key Laboratory of Molecular Cancer Epidemiology (Tianjin), Tianjin's Clinical Research Center for Cancer, National Clinical Research Center for Cancer, Tianjin Medical University Cancer Institute and Hospital, Tianjin 300060, China.
Fengju SongDepartment of Cancer Epidemiology and Biostatistics, Key Laboratory of Molecular Cancer Epidemiology (Tianjin), Tianjin's Clinical Research Center for Cancer, National Clinical Research Center for Cancer, Tianjin Medical University Cancer Institute and Hospital, Tianjin 300060, China.ORCID 0000-0003-1542-0828
Kexin ChenDepartment of Cancer Epidemiology and Biostatistics, Key Laboratory of Molecular Cancer Epidemiology (Tianjin), Tianjin's Clinical Research Center for Cancer, National Clinical Research Center for Cancer, Tianjin Medical University Cancer Institute and Hospital, Tianjin 300060, China.ORCID 0000-0003-1010-8093
C-BLAST Group
Tianjin Medical University Cancer Institute and Hospital · CN
Funding
No grant is acknowledged in the PubMed record.
Abstract
PubMed holds no abstract for this paper.
Indexed as
Early Detection of CancerEast Asian PeopleNeoplasmsColorectal NeoplasmsHumansLiverLungStomach Neoplasms
Identifiers
What OpenQuestion holds
Textmetadata
LicenceCC BY
Read underepoch 390
Registered trials
None linked
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.